A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression
- Conditions
- Depressive Disorder, Major
- Interventions
- First Posted Date
- 2020-08-20
- Last Posted Date
- 2025-03-06
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 389
- Registration Number
- NCT04521478
- Locations
- 🇺🇸
CT Clinical Research, Cromwell, Connecticut, United States
🇺🇸Institute of Living, Hartford, Connecticut, United States
🇺🇸Gulf Coast Clinical Research Center, Fort Myers, Florida, United States
EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)
- First Posted Date
- 2020-08-12
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 6522
- Registration Number
- NCT04509674
- Locations
- 🇺🇸
Charlotte Heart Group Research Center, Port Charlotte, Florida, United States
🇦🇺Royal Brisbane and Women's Hospital, Herston, Queensland, Australia
🇺🇸Penn Presbyterian Medical Center, Philadelphia, Pennsylvania, United States
A Study to Test BI 754091 Alone or in Combination With BI 836880 in People Who Have Advanced Anal Cancer
- Conditions
- Anal Canal Squamous Cell Carcinoma
- Interventions
- First Posted Date
- 2020-08-05
- Last Posted Date
- 2021-11-15
- Lead Sponsor
- Boehringer Ingelheim
- Registration Number
- NCT04499352
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
A Study to Test Long-term Treatment With Spesolimab in People With Palmoplantar Pustulosis (PPP) Who Took Part in Previous Studies With Spesolimab
- First Posted Date
- 2020-07-30
- Last Posted Date
- 2024-03-20
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 108
- Registration Number
- NCT04493424
- Locations
- 🇵🇱
Dermoklinika medical center, Lodz, Lodz, Poland
🇩🇪Universitätsklinikum Frankfurt, Frankfurt am Main, Germany
🇩🇪Charité - Universitätsmedizin Berlin, Berlin, Germany
A Study to Test How Well Different Doses of BI 1356225 Are Tolerated by Men and Women With Obesity or Overweight
- First Posted Date
- 2020-06-25
- Last Posted Date
- 2021-05-19
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 87
- Registration Number
- NCT04447261
- Locations
- 🇩🇪
CRS Clinical Research Services Mannheim GmbH, Mannheim, Germany
A Study in Healthy Men to Test How Well Different Doses of BI 1569912 Are Tolerated and How Food Influences the Amount of BI 1569912 in the Blood
- First Posted Date
- 2020-06-24
- Last Posted Date
- 2021-11-12
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 68
- Registration Number
- NCT04445090
- Locations
- 🇩🇪
Charité - Universitätsmedizin Berlin, Berlin, Germany
A Study in Healthy Men to Test How Different Doses of BI 1595043 Are Tolerated
- First Posted Date
- 2020-06-19
- Last Posted Date
- 2024-02-21
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 64
- Registration Number
- NCT04439838
- Locations
- 🇧🇪
SGS Life Science Services - Clinical Research, Edegem, Belgium
A Study to Test Different Doses of BI 764532 in Patients With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3
- Conditions
- Patients With Small Cell Lung Carcinoma and Other Neoplasms
- Interventions
- Drug: BI 764532 - parenteral 1Drug: BI 764532 - parenteral 2
- First Posted Date
- 2020-06-12
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 282
- Registration Number
- NCT04429087
- Locations
- 🇪🇸
Hospital Vall d'Hebron, Barcelona, Spain
🇩🇪Universitätsklinikum Köln (AöR), Köln, Germany
🇩🇪Universitätsklinikum Würzburg AÖR, Würzburg, Germany
A Study in Healthy Men to Test How BI 1358894 is Taken up in the Body and How Food Influences the Amount of BI 1358894 in the Blood
- Conditions
- Healthy
- Interventions
- Drug: BI 1358894 (C-14) intravenous solution
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 12
- Registration Number
- NCT04426851
- Locations
- 🇳🇱
ICON, Groningen, Netherlands
A Home-based Study Using Mobile Technology to Test Whether BI 1358894 is Effective in People With Depression
- First Posted Date
- 2020-06-09
- Last Posted Date
- 2023-06-13
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 45
- Registration Number
- NCT04423757
- Locations
- 🇺🇸
Science 37, Inc., Culver City, California, United States